Skip to main content
logo
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.800
-0.040 (-1.41%)
At close: Jul 18, 2025, 4:00 PM
2.570
-0.230 (-8.21%)
After-hours: Jul 18, 2025, 4:04 PM EDT

SAB Biotherapeutics Revenue

SAB Biotherapeutics had revenue of $377.84K in the twelve months ending March 31, 2025, down -85.48% year-over-year. In the year 2024, SAB Biotherapeutics had annual revenue of $1.32M, down -40.94%.

Revenue (ttm)
$377.84K
Revenue Growth
-85.48%
P/S Ratio
69.71
Revenue / Employee
$5,997
Employees
63
Market Cap
26.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.32M-916.58K-40.94%
Dec 31, 20232.24M-21.67M-90.63%
Dec 31, 202223.90M-36.97M-60.73%
Dec 31, 202160.88M5.64M10.21%
Dec 31, 202055.24M51.80M1,504.91%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson89.33B
Merck & Co.63.92B
AbbVie57.37B
AstraZeneca54.98B
Novartis AG53.22B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings

SABS News

More News